Kinsmen Laboratory of Neurological Research, University of British Columbia, 2255 Wesbrook Mall, Vancouver, British Columbia, Canada V6T 1Z3.
Curr Protein Pept Sci. 2013 Feb;14(1):21-32. doi: 10.2174/1389203711314010005.
Reciprocal interactions between cells caused by release of soluble factors are essential for brain function. So far, little attention has been paid to interactions between neurons and glia. However, in the last few decades, studies regarding such interactions have given us some important clues about possible mechanisms underlying degenerative processes in neurological diseases such as Alzheimer's disease and Parkinson's disease. Activated microglia and markers of inflammatory reactions have been consistently found in the post-mortem brains of diseased patients. But it has not been clearly understood how microglia respond to neurotransmitters released from neurons during disease progression. The main purpose of this review is to summarize studies performed on neurotransmitter receptor expression in microglia, and the effects of their activation on microglial-mediated neuroinflammation. A possible mechanism underlying transmitter-mediated modulation of microglial response is also suggested. Microglia express receptors for neurotransmitters such as ATP, adenosine, glutamate, GABA, acetylcholine, dopamine and adrenaline. Activation of GABA, cholinergic and adrenergic receptors suppresses microglial responses, whereas activation of ATP or adenosine receptors activates them. This latter effect may be due primarily to activation of a Ca(2+)-signaling pathway which, in turn, results in activation of MAP kinases and NFkB proteins with the release of proinflammatory factors. However, glutamate and dopamine are both pro- and anti-inflammatory depending on the receptor subtypes expressed in microglia. More detailed studies on downstream receptor-signaling cascades are needed to understand the roles of neurotransmitters in controlling neuron-microglia interactions during inflammatory processes in disease progression. Such knowledge may suggest new methods of treatment.
细胞间通过释放可溶性因子而产生的相互作用对于大脑功能至关重要。到目前为止,人们对神经元和神经胶质细胞之间的相互作用关注甚少。然而,在过去几十年中,关于这些相互作用的研究为我们了解阿尔茨海默病和帕金森病等神经退行性疾病中潜在退化过程的可能机制提供了一些重要线索。在患病患者的死后大脑中,始终发现有激活的小胶质细胞和炎症反应标志物。但是,人们尚不清楚小胶质细胞如何应对神经元在疾病进展过程中释放的神经递质。本篇综述的主要目的是总结关于小胶质细胞中神经递质受体表达的研究,以及它们的激活对小胶质细胞介导的神经炎症的影响。还提出了递质介导的小胶质细胞反应调制的可能机制。小胶质细胞表达神经递质的受体,例如 ATP、腺苷、谷氨酸、GABA、乙酰胆碱、多巴胺和肾上腺素。GABA、胆碱能和肾上腺素能受体的激活抑制小胶质细胞的反应,而 ATP 或腺苷受体的激活则激活它们。后一种作用可能主要归因于 Ca(2+)信号通路的激活,该信号通路转而导致 MAP 激酶和 NFkB 蛋白的激活,从而释放促炎因子。但是,谷氨酸和多巴胺均具有促炎和抗炎作用,具体取决于小胶质细胞中表达的受体亚型。需要对下游受体信号转导级联进行更详细的研究,以了解在疾病进展过程中的炎症过程中,神经递质在控制神经元-小胶质细胞相互作用中的作用。这种知识可能提示新的治疗方法。